Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer: Relation to clinicopathological factors, β-catenin and prognosis

Lung Cancer

Volumn 51, Issue 3, 2006, Pages 313-321

  Leinonen, Tero ^a   Pirinen, Risto ^a   Böhm, Jan ^a   Johansson, Risto ^a   Ropponen, Kirsi ^a   Kosma, Veli Matti ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Catenin; Lung cancer; MMP 7; MMP 9; Prognosis

Indexed keywords

BETA CATENIN; GELATINASE B; MATRILYSIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR CELL; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; BETA CATENIN; CARCINOMA, NON-SMALL-CELL LUNG; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33144467105     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.11.002     Document Type: Article

References (45)

1. H. Minamoto, L. Antonangelo, A.G. da Silva, C.P. Gallo, F.B. de Andrade e Silva, and S. Fenezelian Tumour Cell and stromal features in metastatic and non-metastatic non-small cell lung carcinomas Histopathology 43 2003 427 443
2. R.M. Huber, and D.F. Stratakis Molecular oncology - perspectives in lung cancer Lung Cancer 45 Suppl. 2 2004 S209 S213
3. C.A. Granville, and P.A. Dennis An overview of lung cancer genomics and proteomics Am J Respir Cell Mol Biol 32 2005 169 176
4. R. Visse, and H. Nagase Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry Circ Res 92 2003 827 839
5. J.D. Mott, and Z. Werb Regulation of matrix biology by matrix metalloproteinases Curr Opin Cell Biol 16 2004 558 564
6. E. Mira, R.A. Lacalle, J.M. Buesa, G. de Buitrago, S. Jimenez-Baranda, and C. Gomez-Mouton Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface J Cell Sci 117 2004 1847 1857
7. M. Polette, B. Nawrocki-Raby, C. Gilles, C. Vlave, and P. Birembaut Tumour invasion and matrix metalloproteinases Crit Rev Oncol Hematol 49 2004 179 186
8. Y. Tanioka, T. Yoshida, T. Yagawa, Y. Saiki, S. Takeo, and T. Harada Matrix metallopr/oteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer Br J Cancer 89 2003 2116 2121
9. T. Kitoh, H. Yanai, Y. Saitoh, Y. Nakamura, Y. Matsubara, and H. Kitoh Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer J Gastroenterol 39 2004 434 440
10. T. Masaki, H. Matsuoka, M. Sugiyama, N. Abe, A. Goto, and A. Sakamoto Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas Br J Cancer 84 2001 1317 1321
11. L.E. Jones, M.J. Humphreys, F. Campbell, J.P. Neoptolemos, and M.T. Boyd Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival Clin Cancer Res 10 2004 2832 2845
12. K. Yamashita, M. Mori, T. Shiraishi, K. Shibuta, and K. Sugimachi Clinical significance of matrix metalloproteinase-7 expression in esophageal carcinoma Clin Cancer Res 6 2000 1169 1174
13. N. Kawano, H. Osawa, T. Ito, Y. Nagashima, F. Hirahara, and Y. Inayama Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsin(ogen) in lung neoplasms: an immunohistochemical study Hum Pathol 28 1997 613 622
14. H. Sasaki, H. Yukiue, S. Moiriyama, Y. Kobayashi, Y. Nakashima, and M. Kaji Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer J Surg Res 101 2001 242 247
15. T.S. Lin, S.H. Chiou, L.S. Wang, H.H. Huang, S.F. Chiang, and A.Y.H. Shih Expression spectra of matrix metalloproteinases in metastatic non-small cell lung cancer Oncol Rep 12 2004 717 723
16. M. Bienz Beta-catenin: a pivot between cell adhesion and Wnt signalling Curr Biol 15 2005 R64 R67
17. T. Brabletz, A. Jung, S. Dag, F. Hlubek, and T. Kirchner Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer Am J Pathol 155 1999 1033 1038
18. A.V. Ougolkov, K. Yamashita, M. Mai, and T. Minamoto Oncogenic beta-catenin and MMP-7 (matrilysin) cosegregate in late-stage clinical colon cancer Gastroenterology 122 2002 60 71
19. L.C. van Kempen, and L.M. Coussens MMP-9 potentiates pulmonary metastasis formation Cancer Cell 2 2002 251 252
20. K. Saito, S. Takeha, K. Shiba, S. Matsuno, T. Sorsa, and H. Nagura Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: functional multiplicity of matrix degradation on hematogenous metastasis Int J Cancer 86 2000 24 29
21. J.M. Pellikainen, K.M. Ropponen, V.V. Kataja, J.K. Kellokoski, M.J. Eskelinen, and V.M. Kosma Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis Clin Cancer Res 10 2004 7621 7628
22. G. Cox, J.L. Jones, and K.J. O'Byrne Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer Clin Cancer Res 6 2000 2349 2355
23. W. Sienel, J. Hellers, A. Morresi-Hauf, R. Lichtninghagen, W. Mutschler, and M. Jochum Prognostic impact of matrix metalloproteinase-9 in operable non-small cell lung cancer Int J Cancer 103 2003 647 651
24. F. Kumaki, K. Matsui, T. Kawai, Y. Ozeki, Z.X. Yu, and V.J. Ferrans Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia Am J Pathol 159 2001 2125 2135
25. A. Schutz, D. Schneidenbach, G. Aust, A. Tannapfel, M. Steinert, and C. Wittekind Differential expression and activity status of MMP-1, MMP-2 and MMP-9 in tumor and stromal cells of squamous cell carcinomas of the lung Tumour Biol 23 2002 179 184
26. S. Ishikawa, K. Takenaka, K. Yanagihara, R. Miyahara, Y. Kawano, and Y. Otake Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer Clin Cancer Res 10 2004 6579 6585
27. R. Pirinen, P. Hirvikoski, J. Bohm, J. Kellokoski, K. Moisio, and M. Viren Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma Hum Pathol 31 2000 1088 1095
28. W.D. Travis, E. Brambilla, H.K. Muller-Hermelink, and C.C. Harris Tumours of the lung, pleura, thymus, and heart 1st ed. 2004 IARC Press Lyon
29. D.E. Swinson, G. Cox, and K.J. O'Byrne Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer Br J Cancer 91 2004 1301 1307
30. R.T. Pirinen, P. Hirvikoski, R.T. Johansson, S. Hollmen, and V.M. Kosma Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer J Clin Pathol 54 2001 391 395
31. L.M. Coussens, C.L. Tinkle, D. Hanahan, and Z. Werb MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis Cell 103 2000 481 490
32. N. Fujise, A. Nanashim, Y. Taniguchi, S. Matsuo, K. Hatano, and Y. Matsumoto Prognostic impact of cathepsin B and matrix metalloproteinase-9 in pulmonary adenocarcinomas by immunohistochemical study Lung Cancer 27 2000 19 26
33. I. Bolon, E. Brambilla, B. Vandenbunder, C. Robert, S. Lantuejoul, and C. Brambilla Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions Lab Invest 75 1996 1 13
34. F.B. Galateau-Salle, R.E. Luna, K. Horiba, M.N. Sheppard, T. Hayashi, and M.V. Fleming Matrix metalloproteinases and tissue inhibitors of metalloproteinases in bronchial squamous preinvasive lesions Hum Pathol 31 2000 296 305
35. R.C. Jordan, M. Macabeo-Ong, C.H. Shiboski, N. Dekker, D.G. Ginzinger, and D.T. Wong Overexpression of matrix metalloproteinase-1 and -9 mRNA is associated with progression of oral dysplasia to cancer Clin Cancer Res 10 2004 6460 6465
36. J.M. Chiang, Y.H. Chou, T.C. Chen, K.F. Ng, and J.L. Lin Nuclear beta-catenin expression is closely related to ulcerative growth of colorectal carcinoma Br J Cancer 86 2002 1124 1129
37. H. Ueno, K. Yamashita, I. Azumano, M. Inoue, and Y. Okada Enhanced production and activation of matrix metalloproteinase-7 (matrilysin) in human endometrial carcinomas Int J Cancer 84 1999 470 477
38. C.A. Pinto, P.E. Carvalho, L. Antonangelo, A. Garippo, A.G. da Silva, and F. Soares Morphometric evaluation of tumor matrix metalloproteinase 9 predicts survival after surgical resection of adenocarcinoma of the lung Clin Cancer Res 9 2003 3098 3104
39. A. Karameris, P. Panagou, T. Tsilalis, and D. Bouros Association of expression of metalloproteinases and their inhibitors with the metastatic potential of squamous-cell lung carcinomas. A molecular and immunohistochemical study Am J Respir Crit Care Med 156 1997 1930 1936
40. R.S. Herbst, S. Yano, H. Kuniyasu, F.R. Khuri, C.D. Bucana, and F. Guo Differential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma Clin Cancer Res 6 2000 790 797
41. B. Nawrocki, M. Polette, V. Marchand, M. Monteau, P. Gillery, and J.M. Tournier Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analyses Int J Cancer 72 1997 556 564
42. H. Yamamoto, A. Vinitketkumnuen, Y. Adachi, H. Taniguchi, T. Hirata, and N. Miyamoto Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma Carcinogenesis 25 2004 2353 2360
43. N.H. Yamaguchi, A.J. Lichtenfels, L.M. Demarchi, A.P. da Silva, A.L. Garippo, and V.F.A. Alves COX-2, MMP-9, and noguchi classification provide additional prognostic information about adenocarcinoma of the lung. A study of 117 patients from Brazil Am J Clin Pathol 121 2004 78 86
44. H.S. Hofmann, G. Hansen, G. Richter, T. Christiane, A. Simm, and R.E. Silber Matrix metalloproteinase-12 expression correlates with local recurrence and metastatic disease in non-small cell lung cancer patients Clin Cancer Res 11 2005 1086 1092
45. P. Thomas, R. Khokha, F.A. Shepherd, R. Feld, and M.S. Tsao Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer J Pathol 190 2000 150 156